A multi-institutional team of researchers have published research showing how AI was trained to understand the “language” of proteins and can design peptide drugs to target disease proteins – a game-changer for hard-to-treat diseases.
People with Huntington's disease have a mutated version of a protein that ordinarily helps repair DNA damage, affecting their brain cells' ability to heal.
Nine McMaster researchers received funding from the Ontario Research Fund and the Early Researcher Awards Program, designed to support the development of homegrown ideas, products and technologies.